Nantahala Capital Management, LLC Journey Medical Corp Transaction History

Nantahala Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.97 $282,128 - $504,772	169,957 Added 95.1%	348,663 $955,000
Q2 2023 Aug 14, 2023	SELL	$1.03 - $2.26 $34,660 - $76,051	-33,651 Reduced 15.85%	178,706 $284,000
Q1 2023 May 15, 2023	SELL	$1.28 - $2.54 $17,457 - $34,643	-13,639 Reduced 6.04%	212,357 $333,000
Q4 2022 Feb 14, 2023	BUY	$1.14 - $2.85 $257,635 - $644,088	225,996 New	225,996 $433,000

4.66M

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $59.6M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.